investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
The role of the PI3K pathway in immune resistance
Patrick Hwu
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Patrick Hwu
University of Texas MD Anderson Cancer Center
Houston, United States
Related projects
Karlene A Cimprich
Mechanisms Linking Genome Stability to RNA Metabolism
Melanoma of skin
Kunal Rai
Epigenetics of Melanoma Metastasis
Melanoma of skin
Robert S. Dipaola
Cancer Institute of New Jersey - Cancer Center Support Grant
Melanoma of skin
Tina Yuan
A systematic dissection of oncogenic KRAS signaling for target identification and therapeutic development
Melanoma of skin
Zheng Zhou
RECOGNITION OF APOPTOTIC AND NECROTIC CELLS BY THEIR PHAGOCYTES
Melanoma of skin
Peter Sarnow
Modulation of internal ribosome entry by ribosomal protein RPS25
Melanoma of skin
Kimberly A Mccall
Programmed Cell Death in Drosophila Development
Melanoma of skin
Ravi Bhatia
Robust statistical approaches for decoding protein and mRNA expression regulation
Melanoma of skin
Dewi Harjanto
Does the RNA editor Apobec-1 shift microRNA targeting to a tumorigenic effect?
Melanoma of skin
